Search research articles
Contact Us
Filters
Showing results (201-210 of 242) with videos related to
Page
of 25
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica
|
May 7, 2013
[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders]
, Daniel Podzamczer Palter, José A Muñoz-Moreno, et al.
Brain Communications
|
April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome
M Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Nature Medicine
|
February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Katharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Nature Medicine
|
April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
Madison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Brain : a Journal of Neurology
|
July 9, 2015
Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain
Oriol Dols-Icardo, Irene Nebot, Ana Gorostidi, et al.
Frontiers in Aging Neuroscience
|
April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset
Jan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study
James D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's Disease
Aina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Shengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 242) with videos related to
Sort By:
Page
of 25
Enfermedades Infecciosas Y Microbiologia Clinica
|
May 7, 2013
[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders]
, Daniel Podzamczer Palter, José A Muñoz-Moreno, et al.
Brain Communications
|
April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome
M Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Nature Medicine
|
February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Katharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Nature Medicine
|
April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
Madison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Brain : a Journal of Neurology
|
July 9, 2015
Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain
Oriol Dols-Icardo, Irene Nebot, Ana Gorostidi, et al.
Frontiers in Aging Neuroscience
|
April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset
Jan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study
James D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's Disease
Aina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Shengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Page
of 25